The 2518 A/G polymorphism in the MCP-1 gene and cancer risk: A meta-analysis

7Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Background: The 2518 A/G polymorphism in the MCP-1 gene has been extensively studied for association swith cancer; however, results from replication studies have been inconsistent. The aim of this investigation was to determine links with risk of cancer by meta-analysis. Methods: We searched Pubmed, Embase, CNKI, Weipu and Wanfang databases, covering all case-control studies until March, 2013. Statistical analyses were performed using the Revman 5.0 software. Results: A total of 11 case-control studies met our inclusion criteria, including 1,422 cases and 2,237 controls. The results indicated that the MCP-1 2518 gene polymorphism had no association with cancer risk overall (GG vs.GA+AA: OR = 0.89, 95%CI = 0.61-1.28, P = 0.52). However, in the subgroup analysis by ethnicity, a decrease of cancer risk was found in Asian populations (GG vs.GA+AA: OR = 0.79, 95%CI = 0.63-0.99, P = 0.04). Conclusion: This meta-analysis suggested that the 2518A/G polymorphism of MCP-1 gene is associated with risk of cancer among Asian, but not in Caucasian populations.

Cite

CITATION STYLE

APA

Jia, L. Q., Shen, Y. C., Guo, S. J., Hu, Q. J., Pang, C. S., Wang, T., … Wen, F. Q. (2013). The 2518 A/G polymorphism in the MCP-1 gene and cancer risk: A meta-analysis. Asian Pacific Journal of Cancer Prevention, 14(6), 3575–3579. https://doi.org/10.7314/APJCP.2013.14.6.3575

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free